Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system

References

1. Ackermann M., Chou J., Sarmiento M., Lerner R. A., Roizman B. 1986; Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus. Journal of Virology 58:843–850
   [Google Scholar]
2. Ben-Hur T., Hadar J., Shtram Y., Gilden D. H., Becker Y. 1983; N euro virulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Archives of Virology 78:303–308
   [Google Scholar]
3. Bohenzky R. A., Papavassiliou A. G., Gelman I. H., Silverstein S. 1993; Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 U_L region. Journal of Virology 67:632–642
   [Google Scholar]
4. Brandt C. R., Kintner R. L., Pumfery A. M., Visalli R. J., Grau D. R. 1991; The herpes simplex virus ribonucleotide reductase is required for ocular virulence. Journal of General Virology 72:2043–2049
   [Google Scholar]
5. Brown S. M., Ritchie D. A., Subak-Sharpe J. H. 1973; Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. Journal of General Virology 18:329–346
   [Google Scholar]
6. Cai W., Gu B., Person S. 1988; Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. Journal of Virology 62:2596–2604
   [Google Scholar]
7. Cameron J. M., Mcdougall I., Marsden H. S., Preston V. G., Ryan D. M., Subak-Sharpe J. H. 1988; Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and is a valid antiviral target. Journal of General Virology 69:2607–2612
   [Google Scholar]
8. Chou J., Roizman B. 1986; The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. Journal of Virology 57:629–637
   [Google Scholar]
9. Chou J., Roizman B. 1990; The herpes simplex virus 1 gene for ICP34.5 which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17 syn⁺. Journal of Virology 64:1014–1020
   [Google Scholar]
10. Chou J., Kern E. R., Whitley R. J., Roizman B. 1990; Mapping of herpes simplex virus-1 neurovirulence to γ₁34.5, a gene nonessential for growth in culture. Science 250:1262–1265
    [Google Scholar]
11. Darby G., Churcher M., Larder B. A. 1984; Cooperative effects between two acyclovir resistant loci in herpes simplex virus. Journal of Virology 50:836–846
    [Google Scholar]
12. Dolan A, Mckie E., Maclean A. R., McGeoch D. J. 1992; Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. Journal of General Virology 73:971–973
    [Google Scholar]
13. Fuller A. O., Spear P. G. 1987; Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proceedings of the National Academy of Sciences U.S.A.: 845454–5458
    [Google Scholar]
14. Furlong J., Conner J., Mclauchlan J., Lankinen H., Galt C., Marsden H. S., Clements J. B. 1991; The large subunit of herpes simplex virus type 1 ribonucleotide reductase: expression in Escherichia colt and purification. Virology 182:848–851
    [Google Scholar]
15. Izumi K., Stevens J. 1990; Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. Journal of Experimental Medicine 172:487–496
    [Google Scholar]
16. Lankinen H., Mclauchlan J., Weir M., Furlong J., Conner J., Mcgarrity A., Mistry A., Clements J. B., Marsden H. S. 1991; Purification and characterization of the herpes simplex virus type 1 ribonucleotide reductase small subunit following expression in Escherichia coli. Journal of General Virology 72:1383–1392
    [Google Scholar]
17. Larder B. A., Lisle J. J., Darby G. 1986; Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1. Journal of General Virology 67:2501–2506
    [Google Scholar]
18. McGeoch D. J., Cunningham C., McIntyre G., Dolan A. 1991; Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. Journal of General Virology 72:3057–3075
    [Google Scholar]
19. MacKay E. M., McVey B., Marsden H. S., Brown S. M., MacLean A. R. 1993; The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M_r 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F. Journal of General Virology 74:2493–2497
    [Google Scholar]
20. MacLean A. R., Fareed M. U., Robertson L., Harland J., Brown S. M. 1991; Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17⁺ between immediate early gene 1 and the ‘a’ sequence. Journal of General Virology 72:631–639
    [Google Scholar]
21. Macpherson I., Stoker M. G. 1962; Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. Virology 16:147–151
    [Google Scholar]
22. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
23. Morton D. B., Griffiths P. H. M. 1985; Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment. Veterinary Record 116:431–136
    [Google Scholar]
24. Perry L. J., McGeoch D. J. 1988; The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:2831–2846
    [Google Scholar]
25. Pyles R. B., Sawtell N. M., Thompson R. L. 1992; Herpes simplex virus dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness and reactivation from latency. Journal of Virology 66:6706–6713
    [Google Scholar]
26. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
27. Robertson L. M., MacLean A. R., Brown S.M. 1992; Peripheral replication and latency reactivation kinetics of the nonneurovirulent herpes simplex virus type 1 variant 1716. Journal of General Virology 73:976–970
    [Google Scholar]
28. Southern E. M. 1975; Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503–517
    [Google Scholar]
29. Stow N. D., Wilkie N. M. 1976; An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA. Journal of General Virology 33:447–459
    [Google Scholar]
30. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. S. 1990; Use of T7 RNA polymerase to direct expression of cloned genes. Methods in Enzymology 185:60–89
    [Google Scholar]
31. Taha Y. M., Clements G. B., Brown S. M. 1989a; A variant of herpes simplex virus type 2 strain HG52 with a 1·5 kb deletion in R _Lbetween 0 to 0·02 and 0·81 to 0·83 map units is non-neurovirulent for mice. Journal of General Virology 70:705–716
    [Google Scholar]
32. Taha M. Y., Clements G. B., Brown S. M. 1989b; The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neuro virulence in mice. Journal of General Virology 70:3073–3078
    [Google Scholar]
33. Tenser R. B., Ressel S., Dunstan M. E. 1981; Herpes simplex virus thymidine kinase expression m trigeminal ganglia: correlation of enzyme activity with ganglion virus titre and evidence of in vivo complementation. Virology 112:328–314
    [Google Scholar]
34. Thompson R. L., Wagner E. K. 1988; Partial rescue of herpes simplex virus neurovirulence with a 3·2 kb cloned fragment. Virus Genes 1:261–273
    [Google Scholar]
35. Thompson R. L., Wagner E. K., Stevens J. G. 1983; Physical location of a herpes simplex virus type 1 function(s) specifically involved with a 10 million fold increase in HSV neurovirulence. Virology 131:180–192
    [Google Scholar]
36. Thompson R. L., Rogers S. K., Zerhusen M. A. 1989; Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0·82–0·832 map units on the HSV genome. Virology 172:435–150
    [Google Scholar]
37. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences U.S.A: 764350–4354
    [Google Scholar]
38. Whitley R. J. 1985; Epidemiology of herpes simplex viruses. In The Herpesviruses 3 pp 1–14 Roizman B. Edited by New York & London: Plenum Press;
    [Google Scholar]
39. Yuhaz S. A., Stevens J. G. 1993; Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. Journal of Virology 67:5948–5954
    [Google Scholar]